Literature DB >> 26743065

Unusual presentations and intrafamilial phenotypic variability in infantile onset Alexander disease.

Davide Tonduti1,2, Anna Ardissone3, Isabella Ceccherini4, Giorgio Giaccone5, Laura Farina6, Isabella Moroni3.   

Abstract

Alexander disease is an hereditary leukodystrophy related to mutations of GFAP. Classically AxD was divided in infantile, juvenile, and adult subgroups. Recent data suggested considering only two subtypes: type I (infantile onset with lesions extending to the cerebral hemispheres); type II (adult onset with primary involvement of subtentorial structures). We report two related and one unrelated patients presenting with a peculiar association of clinical and neuroradiological features. GFAP analysis disclosed the presence of one novel and two previously reported mutations. Our patients underline the importance of considering AxD in patients with bulbar symptoms and autonomic dysfunction even if MRI shows only posterior fossa abnormalities, supporting the hypothesis of a third type of AxD sharing features of both type I and type II. The evidence of an intrafamilial phenotypic variability suggests the possible role of still unknown factors influencing the effect of GFAP mutation and determining the phenotype.

Entities:  

Keywords:  Alexander disease; GFAP; Leukodystrophy; White matter

Mesh:

Substances:

Year:  2016        PMID: 26743065     DOI: 10.1007/s10072-015-2466-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

1.  Determination of the gene structure of human GFAP and absence of coding region mutations associated with frontotemporal dementia with parkinsonism linked to chromosome 17.

Authors:  A Isaacs; M Baker; F Wavrant-De Vrièze; M Hutton
Journal:  Genomics       Date:  1998-07-01       Impact factor: 5.736

2.  Alexander disease: diagnosis with MR imaging.

Authors:  M S van der Knaap; S Naidu; S N Breiter; S Blaser; H Stroink; S Springer; J C Begeer; R van Coster; P G Barth; N H Thomas; J Valk; J M Powers
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

3.  Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation.

Authors:  D Rodriguez; F Gauthier; E Bertini; M Bugiani; M Brenner; S N'guyen; C Goizet; A Gelot; R Surtees; J M Pedespan; X Hernandorena; M Troncoso; G Uziel; A Messing; G Ponsot; D Pham-Dinh; A Dautigny; O Boespflug-Tanguy
Journal:  Am J Hum Genet       Date:  2001-09-20       Impact factor: 11.025

4.  Familial adult-onset Alexander disease with a novel mutation (D78N) in the glial fibrillary acidic protein gene with unusual bilateral basal ganglia involvement.

Authors:  Yuko Wada; Chie Yanagihara; Yo Nishimura; Michito Namekawa
Journal:  J Neurol Sci       Date:  2013-06-04       Impact factor: 3.181

5.  Glial fibrillary acidic protein mutations in adult-onset Alexander disease: clinical features observed in 12 Japanese patients.

Authors:  T Yoshida; H Sasayama; I Mizuta; Y Okamoto; M Yoshida; Y Riku; Y Hayashi; T Yonezu; Y Takata; K Ohnari; S Okuda; I Aiba; M Nakagawa
Journal:  Acta Neurol Scand       Date:  2010-09-16       Impact factor: 3.209

6.  Adult Alexander disease with autosomal dominant transmission: a distinct entity caused by mutation in the glial fibrillary acid protein gene.

Authors:  Erika Stumpf; Hélène Masson; Antoine Duquette; France Berthelet; Julia McNabb; Anne Lortie; Jacques Lesage; Jacques Montplaisir; Bernard Brais; Patrick Cossette
Journal:  Arch Neurol       Date:  2003-09

7.  Can MR imaging diagnose adult-onset Alexander disease?

Authors:  L Farina; D Pareyson; L Minati; I Ceccherini; L Chiapparini; S Romano; P Gambaro; R Fancellu; M Savoiardo
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-03       Impact factor: 3.825

Review 8.  Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature.

Authors:  Davide Pareyson; Roberto Fancellu; Caterina Mariotti; Silvia Romano; Andrea Salmaggi; Francesco Carella; Floriano Girotti; Grazietta Gattellaro; Maria Rita Carriero; Laura Farina; Isabella Ceccherini; Mario Savoiardo
Journal:  Brain       Date:  2008-08-06       Impact factor: 13.501

9.  Neuroimaging and clinical features in type II (late-onset) Alexander disease.

Authors:  Jonathan Graff-Radford; Kara Schwartz; Ralitza H Gavrilova; Daniel H Lachance; Neeraj Kumar
Journal:  Neurology       Date:  2013-12-04       Impact factor: 9.910

10.  GFAP mutations, age at onset, and clinical subtypes in Alexander disease.

Authors:  M Prust; J Wang; H Morizono; A Messing; M Brenner; E Gordon; T Hartka; A Sokohl; R Schiffmann; H Gordish-Dressman; R Albin; H Amartino; K Brockman; A Dinopoulos; M T Dotti; D Fain; R Fernandez; J Ferreira; J Fleming; D Gill; M Griebel; H Heilstedt; P Kaplan; D Lewis; M Nakagawa; R Pedersen; A Reddy; Y Sawaishi; M Schneider; E Sherr; Y Takiyama; K Wakabayashi; J R Gorospe; A Vanderver
Journal:  Neurology       Date:  2011-09-14       Impact factor: 11.800

View more
  4 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

2.  A novel in-frame GFAP p.E138_L148del mutation in Type II Alexander disease with atypical phenotypes.

Authors:  You-Ri Kang; So-Hyun Lee; Ni-Hsuan Lin; Seung-Jin Lee; Ai-Wen Yang; Gopalakrishnan Chandrasekaran; Kyung Wook Kang; Mi Sun Jin; Myeong-Kyu Kim; Ming-Der Perng; Seok-Yong Choi; Tai-Seung Nam
Journal:  Eur J Hum Genet       Date:  2022-03-04       Impact factor: 5.351

3.  Infantile Alexander Disease with Late Onset Infantile Spasms and Hypsarrhythmia.

Authors:  J Paprocka; B Rzepka-Migut; N Rzepka; A Jezela-Stanek; E Morava
Journal:  Balkan J Med Genet       Date:  2019-12-21       Impact factor: 0.519

4.  Does genetic anticipation occur in familial Alexander disease?

Authors:  Camille K Hunt; Ahmad Al Khleifat; Ella Burchill; Joerg Ederle; Ammar Al-Chalabi; Jemeen Sreedharan
Journal:  Neurogenetics       Date:  2021-05-28       Impact factor: 2.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.